FDA accepts Airway’s IND for AT-100 for bronchopulmonary dysplasia treatment in preterm infants
Bronchopulmonary dysplasia treatment : Airway Therapeutics said that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for developing ... Read More
Here’s why the body may reject lung transplants
New Delhi, Mar 05 (ANI): A study led by researchers at Washington University School of Medicine in St. Louis, has identified, in mice, a process ... Read More